<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en"><title>The latest in Prostate Cancer</title><link href="http://www.fluinthenews.com/topic/Prostate%20Cancer" rel="alternate"></link><id>http://www.fluinthenews.com/topic/Prostate Cancer</id><updated>2010-03-13T12:15:38Z</updated><entry><title>Growing doubts over standard prostate cancer test</title><link href="http://www.fluinthenews.com/article/Growing%20doubts%20over%20standard%20prostate%20cancer%20test" rel="alternate"></link><updated>2010-03-13T12:15:38Z</updated><author><name>AFP Global Edition</name></author><id>tag:www.fluinthenews.com,2010-03-13:/article/Growing%20doubts%20over%20standard%20prostate%20cancer%20test</id><summary type="html">&amp;lt;div&amp;gt;&amp;lt;p&amp;gt;The most commonly used prostate cancer screening procedure, PSA, is at the center of a growing debate after its discoverer said it had become a "hugely expensive public health disaster."&amp;lt;/p&amp;gt;&amp;lt;p&amp;gt;In a commentary in &lt;a title="The New York Times Company" href="/topic/The+New+York+Times+Company" &gt;The New York Times&lt;/a&gt;, &lt;a title="Richard Ablin" href="/topic/Richard+Ablin" &gt;Richard Ablin&lt;/a&gt; of the &lt;a title="University of Arizona" href="/topic/University+of+Arizona" &gt;Uni...</summary><category term="Cancer"></category><category term="Prostate Cancer"></category><category term="Sexual and Reproductive Health"></category><category term="Medicare"></category><category term="Men's Health"></category><category term="Richard Ablin"></category></entry><entry><title>Experts say even Obama getting too many med tests</title><link href="http://www.fluinthenews.com/article/Experts%20say%20even%20Obama%20getting%20too%20many%20med%20tests" rel="alternate"></link><updated>2010-03-12T13:45:11Z</updated><author><name>AP News</name></author><id>tag:www.fluinthenews.com,2010-03-12:/article/Experts%20say%20even%20Obama%20getting%20too%20many%20med%20tests</id><summary type="html">&amp;lt;div id="subtitle"&amp;gt;Experts say Americans getting too many medical tests, maybe even &lt;a title="Barack Obama" href="/topic/Barack+Obama" &gt;President Obama&lt;/a&gt;&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;&amp;lt;p&amp;gt;Too much cancer screening, too many heart tests, too many cesarean sections. A spate of recent reports suggests that many Americans are being overtreated. Maybe even President Barack Obama, champion of an overhaul and cost-cutting of the health care system.&amp;lt;/p&amp;gt;&amp;lt;p&amp;gt;Is it doctors practicing defens...</summary><category term="Cancer"></category><category term="Breast Cancer"></category><category term="Prostate Cancer"></category><category term="Medical Treatments and Procedures"></category><category term="Mammography"></category><category term="Sexual and Reproductive Health"></category><category term="The White House"></category><category term="Men's Health"></category><category term="Barack Obama"></category><category term="Medical Imaging and Diagnostics"></category><category term="Peter Pronovost"></category><category term="Foundation for Informed Medical Decision Making"></category><category term="Richard Wender"></category><category term="Gilbert Welch"></category><category term="Rita Redberg"></category><category term="Bitly Inc."></category><category term="Bruce Minsky"></category></entry><entry><title>Guidelines: Do medical tests later, less often</title><link href="http://www.fluinthenews.com/article/Guidelines%3A%20Do%20medical%20tests%20later%2C%20less%20often" rel="alternate"></link><updated>2010-03-12T02:45:19Z</updated><author><name>AP News</name></author><id>tag:www.fluinthenews.com,2010-03-12:/article/Guidelines%3A%20Do%20medical%20tests%20later%2C%20less%20often</id><summary type="html">&amp;lt;div id="subtitle"&amp;gt;Are some medical tests overused? Some guidelines are scaling back on frequency, timing&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;&amp;lt;p&amp;gt;Recent reports and guideline changes suggest some medical tests should be delayed, avoided, or done less often:&amp;lt;/p&amp;gt;&amp;lt;p&amp;gt;_ MAMMOGRAM: Most women don't need a mammogram in their 40s and they should get one every two years starting at 50, according to the &lt;a title="U.S. Preventive Services Task Force" href="/topic/U.S.+Preventive+Services+Task+Forc...</summary><category term="Cancer"></category><category term="Breast Cancer"></category><category term="Cervical Cancer"></category><category term="Prostate Cancer"></category><category term="Medical Treatments and Procedures"></category><category term="Mammography"></category><category term="Surgery"></category><category term="Sexual and Reproductive Health"></category><category term="Men's Health"></category><category term="Women's Health"></category><category term="Prenatal Health, Labor and Delivery"></category><category term="Medical Imaging and Diagnostics"></category></entry><entry><title>Watson says FDA approves 6-month dose Trelstar</title><link href="http://www.fluinthenews.com/article/Watson%20says%20FDA%20approves%206-month%20dose%20Trelstar" rel="alternate"></link><updated>2010-03-11T15:00:28Z</updated><author><name>AP News</name></author><id>tag:www.fluinthenews.com,2010-03-11:/article/Watson%20says%20FDA%20approves%206-month%20dose%20Trelstar</id><summary type="html">&amp;lt;div id="subtitle"&amp;gt;&lt;a title="Watson Pharmaceuticals Inc." href="/topic/Watson+Pharmaceuticals+Inc." &gt;Watson Pharmaceuticals&lt;/a&gt; says FDA approves 6-month dose of prostate cancer drug Trelstar&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;&amp;lt;p&amp;gt;Watson Pharmaceuticals Inc. said the &lt;a title="Food and Drug Administration" href="/topic/Food+and+Drug+Administration" &gt;Food and Drug Administration&lt;/a&gt; approved a six-month dose of the prostate cancer drug Trelstar, which already was available in one- and three-month d...</summary><category term="Cancer"></category><category term="Prostate Cancer"></category><category term="Medical Treatments and Procedures"></category><category term="Medical Drug Therapy"></category><category term="Sexual and Reproductive Health"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="Men's Health"></category><category term="Western Europe"></category><category term="Watson Pharmaceuticals Inc."></category><category term="Chemotherapy"></category><category term="Debiopharm SA"></category></entry><entry><title>Prostate test 'public health disaster': discoverer</title><link href="http://www.fluinthenews.com/article/Prostate%20test%20%27public%20health%20disaster%27%3A%20discoverer" rel="alternate"></link><updated>2010-03-10T14:18:31Z</updated><author><name>Reuters US Online Report Health News</name></author><id>tag:www.fluinthenews.com,2010-03-10:/article/Prostate%20test%20%27public%20health%20disaster%27%3A%20discoverer</id><summary type="html">&amp;lt;div&amp;gt;&amp;lt;p&amp;gt;WASHINGTON (&lt;a title="Reuters Group plc" href="/topic/Reuters+Group+plc" &gt;Reuters&lt;/a&gt;) - The most commonly used tool for detecting prostate cancer, routine PSA screening, has become "a hugely expensive public health disaster," its discoverer said on Wednesday.&amp;lt;/p&amp;gt;&amp;lt;p&amp;gt;Dr. &lt;a title="Richard Ablin" href="/topic/Richard+Ablin" &gt;Richard Ablin&lt;/a&gt; of the &lt;a title="University of Arizona" href="/topic/University+of+Arizona" &gt;University of Arizona&lt;/a&gt; joined the ongoing deb...</summary><category term="Cancer"></category><category term="Prostate Cancer"></category><category term="Sexual and Reproductive Health"></category><category term="Medicare"></category><category term="Men's Health"></category><category term="Reuters Group plc"></category><category term="Maggie Fox"></category><category term="Richard Ablin"></category></entry><entry><title>Specialty may bias doctors' prostate cancer advice</title><link href="http://www.fluinthenews.com/article/Specialty%20may%20bias%20doctors%27%20prostate%20cancer%20advice" rel="alternate"></link><updated>2010-03-08T13:46:23Z</updated><author><name>Reuters US Online Report Health News</name></author><id>tag:www.fluinthenews.com,2010-03-08:/article/Specialty%20may%20bias%20doctors%27%20prostate%20cancer%20advice</id><summary type="html">&amp;lt;div&amp;gt;&amp;lt;p&amp;gt;NEW YORK (&lt;a title="Reuters Group plc" href="/topic/Reuters+Group+plc" &gt;Reuters Health&lt;/a&gt;) - New research suggests that the type of specialist a prostate cancer patient sees -- rather than the patient's own preference -- may determine the treatment he receives.&amp;lt;/p&amp;gt;&amp;lt;p&amp;gt;This is problematic, the study's authors say, because none of the options now available for treating localized prostate cancer have been shown to be any better than the others.&amp;lt;/p&amp;gt;&amp;lt;p&amp;gt;"The...</summary><category term="Cancer"></category><category term="Prostate Cancer"></category><category term="Kidney and Urologic Health"></category><category term="Medical Treatments and Procedures"></category><category term="Medical Drug Therapy"></category><category term="Sexual and Reproductive Health"></category><category term="Technology"></category><category term="Medical Technology"></category><category term="Nuclear Medicine"></category><category term="Medicare"></category><category term="Men's Health"></category><category term="Reuters Group plc"></category><category term="New Brunswick"></category><category term="Memorial-Sloan Kettering Cancer Center"></category><category term="The Cancer Institute of New Jersey"></category><category term="Hormone Therapies"></category><category term="Thomas Jang"></category></entry><entry><title>Cancer society casts more doubt on prostate tests</title><link href="http://www.fluinthenews.com/article/Cancer%20society%20casts%20more%20doubt%20on%20prostate%20tests" rel="alternate"></link><updated>2010-03-04T00:45:40Z</updated><author><name>AP News</name></author><id>tag:www.fluinthenews.com,2010-03-04:/article/Cancer%20society%20casts%20more%20doubt%20on%20prostate%20tests</id><summary type="html">&amp;lt;div id="subtitle"&amp;gt;&lt;a title="American Cancer Society" href="/topic/American+Cancer+Society" &gt;American Cancer Society&lt;/a&gt; casts more doubt on value of regular testing for prostate cancer&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;&amp;lt;p&amp;gt;Months after experts discounted the importance of routine mammograms and Pap smears for many women, the American Cancer Society is warning more explicitly than ever that regular testing for prostate cancer is of questionable value too, and can do men more harm than good.&amp;lt;/p...</summary><category term="Cancer"></category><category term="Prostate Cancer"></category><category term="Kidney and Urologic Health"></category><category term="Sexual and Reproductive Health"></category><category term="Men's Health"></category><category term="The Associated Press"></category><category term="David Roberts"></category><category term="Everybody Loves Raymond"></category><category term="Rudolph Giuliani"></category><category term="Stephanie Nano"></category><category term="Brad Garrett"></category><category term="John Davis"></category><category term="Len Lichtenfeld"></category><category term="Stephen Freedland"></category><category term="Skip Lockwood"></category></entry><entry><title>Sanofi drug shows promise against prostate cancer</title><link href="http://www.fluinthenews.com/article/Sanofi%20drug%20shows%20promise%20against%20prostate%20cancer" rel="alternate"></link><updated>2010-03-03T15:16:06Z</updated><author><name>AP News</name></author><id>tag:www.fluinthenews.com,2010-03-03:/article/Sanofi%20drug%20shows%20promise%20against%20prostate%20cancer</id><summary type="html">&amp;lt;div id="subtitle"&amp;gt;Experimental drug modestly boosts survival in men with advanced prostate cancer, study finds&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;&amp;lt;p&amp;gt;For the first time, an experimental drug has extended the lives of men with advanced prostate cancer who are no longer responding to other treatments and are out of options for fighting the disease, a company-led study found.&amp;lt;/p&amp;gt;&amp;lt;p&amp;gt;The benefit was modest — an extra 10 weeks — but cancer specialists were excited because no chemotherapy un...</summary><category term="Cancer"></category><category term="Prostate Cancer"></category><category term="Medical Treatments and Procedures"></category><category term="Medical Drug Therapy"></category><category term="Vaccines"></category><category term="Sexual and Reproductive Health"></category><category term="Men's Health"></category><category term="OSI Pharmaceuticals Inc."></category><category term="Taxotere"></category><category term="Dendreon Corporation"></category><category term="Nicholas Vogelzang"></category><category term="Chemotherapy"></category><category term="Provenge"></category></entry><entry><title>Should men be tested for prostate cancer?</title><link href="http://www.fluinthenews.com/article/Should%20men%20be%20tested%20for%20prostate%20cancer%3F" rel="alternate"></link><updated>2010-03-03T13:46:03Z</updated><author><name>AP News</name></author><id>tag:www.fluinthenews.com,2010-03-03:/article/Should%20men%20be%20tested%20for%20prostate%20cancer%3F</id><summary type="html">&amp;lt;div id="subtitle"&amp;gt;New advice on prostate cancer screening stresses talking about pros, cons before deciding&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;&amp;lt;p&amp;gt;The &lt;a title="American Cancer Society" href="/topic/American+Cancer+Society" &gt;American Cancer Society&lt;/a&gt; revised its guidelines for prostate cancer screening on Wednesday. The advocacy group is one of many organizations that make such recommendations. Some questions and answers:&amp;lt;/p&amp;gt;&amp;lt;p&amp;gt;Q: What's the advice?&amp;lt;/p&amp;gt;&amp;lt;p&amp;gt;A: The bottom l...</summary><category term="Cancer"></category><category term="Prostate Cancer"></category><category term="Sexual and Reproductive Health"></category><category term="Medicare"></category><category term="Men's Health"></category></entry><entry><title>PROSTATE_CANCER</title><link href="http://www.fluinthenews.com/photo/2168406" rel="alternate"></link><updated>2010-03-03T13:04:17Z</updated><author><name>AP News</name></author><id>tag:www.fluinthenews.com,2010-03-03:/photo/2168406</id><summary type="html">Graphic shows incidence rates for prostate cancer between 1975 and 2006 and highest death rates from prostate cancer by race between 2001 and&lt;div id="copyright"&gt;&lt;div&gt;
        Copyright 2010  &lt;a href="http://www.ap.org"&gt;AP News&lt;/a&gt;&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;p&gt;&lt;/p&gt;&lt;br /&gt;&lt;br /&gt;&lt;/div&gt;...</summary><category term="Cancer"></category><category term="Prostate Cancer"></category><category term="Sexual and Reproductive Health"></category><category term="Men's Health"></category></entry><entry><title>New guidelines on prostate cancer urge frank talk</title><link href="http://www.fluinthenews.com/article/New%20guidelines%20on%20prostate%20cancer%20urge%20frank%20talk" rel="alternate"></link><updated>2010-03-03T10:18:14Z</updated><author><name>Reuters US Online Report Health News</name></author><id>tag:www.fluinthenews.com,2010-03-03:/article/New%20guidelines%20on%20prostate%20cancer%20urge%20frank%20talk</id><summary type="html">&amp;lt;div&amp;gt;&amp;lt;p&amp;gt;&lt;a title="Chicago" href="/topic/Chicago" &gt;CHICAGO&lt;/a&gt; (&lt;a title="Reuters Group plc" href="/topic/Reuters+Group+plc" &gt;Reuters&lt;/a&gt;) - New guidelines from the &lt;a title="American Cancer Society" href="/topic/American+Cancer+Society" &gt;American Cancer Society&lt;/a&gt; urge doctors to make sure their patients fully understand the risks as well as the benefits of prostate cancer screening before any blood is drawn.&amp;lt;/p&amp;gt;&amp;lt;p&amp;gt;The updated guidelines issued on Wednesday reflect the o...</summary><category term="Cancer"></category><category term="Prostate Cancer"></category><category term="Sexual and Reproductive Health"></category><category term="Men's Health"></category><category term="Reuters Group plc"></category><category term="Andrew Wolf"></category><category term="Foundation for Informed Medical Decision Making"></category><category term="Otis Brawley"></category></entry><entry><title>Cigarette smoking may raise prostate cancer risk</title><link href="http://www.fluinthenews.com/article/Cigarette%20smoking%20may%20raise%20prostate%20cancer%20risk" rel="alternate"></link><updated>2010-03-03T10:18:12Z</updated><author><name>Reuters US Online Report Health News</name></author><id>tag:www.fluinthenews.com,2010-03-03:/article/Cigarette%20smoking%20may%20raise%20prostate%20cancer%20risk</id><summary type="html">&amp;lt;div&amp;gt;&amp;lt;p&amp;gt;NEW YORK (&lt;a title="Reuters Group plc" href="/topic/Reuters+Group+plc" &gt;Reuters Health&lt;/a&gt;) - Cigarette smoking may increase a man's risk for developing and dying from prostate cancer, pooled data from 24 studies involving 21,600 men with the disease indicates.&amp;lt;/p&amp;gt;&amp;lt;p&amp;gt;This study "provides good evidence that prostate cancer is likely a smoking-related tumor," &lt;a title="Michael Huncharek" href="/topic/Michael+Huncharek" &gt;Dr. Michael Huncharek&lt;/a&gt;, at Meta-&lt;a title="A...</summary><category term="Cancer"></category><category term="Prostate Cancer"></category><category term="Health Care Issues"></category><category term="Sexual and Reproductive Health"></category><category term="Men's Health"></category><category term="Reuters Group plc"></category><category term="Smoking and Tobacco Use"></category><category term="Michael Huncharek"></category><category term="Analysis Research Inc."></category></entry><entry><title>CNBC hypes bogus short seller report.  Market figures it out for them.  Investors burned. (DNDN)</title><link href="http://www.fluinthenews.com/article/CNBC%20hypes%20bogus%20short%20seller%20report.%20%20Market%20figures%20it%20out%20for%20them.%20%20Investors%20burned.%20%28DNDN%29" rel="alternate"></link><updated>2010-03-02T20:00:15Z</updated><author><name>AlphaNinja</name></author><id>tag:www.fluinthenews.com,2010-03-02:/article/CNBC%20hypes%20bogus%20short%20seller%20report.%20%20Market%20figures%20it%20out%20for%20them.%20%20Investors%20burned.%20%28DNDN%29</id><summary type="html">&lt;p&gt;&lt;p align="center"&gt;&lt;a href="http://3.bp.blogspot.com/_ENU3_782vjk/S4028EmDlCI/AAAAAAAADvk/byuhg_ivrOI/s1600-h/dndn.png"&gt;&lt;img id="BLOGGER_PHOTO_ID_5444067930214208546" alt="" src="http://3.bp.blogspot.com/_ENU3_782vjk/S4028EmDlCI/AAAAAAAADvk/byuhg_ivrOI/s400/dndn.png" border="0" /&gt;&lt;/a&gt;&lt;/p&gt;&lt;br /&gt;&lt;span class="Apple-style-span"&gt;Shares of &lt;a title="Dendreon Corporation" href="/topic/Dendreon+Corporation" &gt;Dendreon&lt;/a&gt; (DNDN) traded down sharply earlier this morning on reports that it would be subje...</summary><category term="Cancer"></category><category term="Prostate Cancer"></category><category term="Sexual and Reproductive Health"></category><category term="Men's Health"></category><category term="CNBC Inc."></category><category term="David Miller"></category><category term="TheStreet.com Inc."></category><category term="Roth Capital Partners LLC"></category><category term="Dendreon Corporation"></category><category term="Provenge"></category><category term="Elliott Favus"></category><category term="John Huckman"></category><category term="Mike Huckman"></category></entry><entry><title>Statins Slow Inflammation in Prostate Tumors</title><link href="http://www.fluinthenews.com/article/Statins%20Slow%20Inflammation%20in%20Prostate%20Tumors" rel="alternate"></link><updated>2010-02-26T00:15:23Z</updated><author><name>consumeraffairs.com</name></author><id>tag:www.fluinthenews.com,2010-02-26:/article/Statins%20Slow%20Inflammation%20in%20Prostate%20Tumors</id><summary type="html">&amp;lt;div id="subtitle"&amp;gt;Anti-cholesterol meds could slow cancer progression&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;&amp;lt;p&amp;gt;Prostate cancer patients who take statins to lower their cholesterol may be getting a secondary benefit: The drugs significantly lower the degree of inflammation within prostate tumors.&amp;lt;/p&amp;gt;&amp;lt;p&amp;gt;That, according to researchers,  may explain in part, why men on statins have a lower risk of disease progression.

&amp;lt;/p&amp;gt;&amp;lt;p&amp;gt;Previous studies have shown that statins reduce syste...</summary><category term="Cancer"></category><category term="Prostate Cancer"></category><category term="Cholesterol"></category><category term="Kidney and Urologic Health"></category><category term="Sexual and Reproductive Health"></category><category term="Men's Health"></category><category term="Durham"></category><category term="Stephen Freedland"></category><category term="Cardiovascular Medicine"></category><category term="Lionel Banez"></category><category term="Duke Prostate Center"></category></entry><entry><title>Is newer prostate surgery really better than the old?</title><link href="http://www.fluinthenews.com/article/Is%20newer%20prostate%20surgery%20really%20better%20than%20the%20old%3F" rel="alternate"></link><updated>2010-02-22T13:45:20Z</updated><author><name>Reuters US Online Report Health News</name></author><id>tag:www.fluinthenews.com,2010-02-22:/article/Is%20newer%20prostate%20surgery%20really%20better%20than%20the%20old%3F</id><summary type="html">&amp;lt;div&amp;gt;&amp;lt;p&amp;gt;NEW YORK (&lt;a title="Reuters Group plc" href="/topic/Reuters+Group+plc" &gt;Reuters Health&lt;/a&gt;) - Robot-assisted laparoscopic, or "keyhole," surgery appears to be no better at reducing side effects than traditional "open" surgery to remove a cancerous prostate gland, according to new study from &lt;a title="Memorial Sloan-Kettering Cancer Center" href="/topic/Memorial+Sloan-Kettering+Cancer+Center" &gt;Memorial Sloan-Kettering Cancer Center&lt;/a&gt; in &lt;a title="New York" href="/topic/New+Y...</summary><category term="Cancer"></category><category term="Prostate Cancer"></category><category term="Kidney and Urologic Health"></category><category term="Medical Treatments and Procedures"></category><category term="Surgery"></category><category term="Sexual and Reproductive Health"></category><category term="Medicare"></category><category term="Men's Health"></category><category term="Reuters Group plc"></category><category term="The George Washington University Hospital"></category><category term="Jason Engel"></category><category term="William Lowrance"></category><category term="Yair Lotan"></category></entry><entry><title>Give That Thing A Rest</title><link href="http://www.fluinthenews.com/article/Give%20That%20Thing%20A%20Rest" rel="alternate"></link><updated>2010-02-21T21:15:18Z</updated><author><name>Men's Fitness</name></author><id>tag:www.fluinthenews.com,2010-02-21:/article/Give%20That%20Thing%20A%20Rest</id><summary type="html">&amp;lt;div&amp;gt;&amp;lt;p&amp;gt;Given the bind that many prominent American men have thrust themselves into — think &lt;a title="Tiger Woods" href="/topic/Tiger+Woods" &gt;Tiger Woods&lt;/a&gt;, &lt;a title="Mark Sanford" href="/topic/Mark+Sanford" &gt;Mark Sanford&lt;/a&gt;, &lt;a title="Eliot Spitzer" href="/topic/Eliot+Spitzer" &gt;Eliot Spitzer&lt;/a&gt;, et al. — it seems it really is possible to have too much of a good thing. And your prostate gland appears to agree.&amp;lt;/p&amp;gt;&amp;lt;p&amp;gt;According to a new research out of the &lt;a title="Uni...</summary><category term="Relationships"></category><category term="Sexuality"></category><category term="Cancer"></category><category term="Prostate Cancer"></category><category term="Sexual and Reproductive Health"></category><category term="Sexually Transmitted Diseases"></category><category term="Men's Health"></category><category term="Western Europe"></category><category term="Men's Fitness Magazine"></category><category term="Tiger Woods"></category><category term="Eliot Spitzer"></category><category term="Mark Sanford"></category><category term="Lorelei Mucci"></category><category term="Polyxeni Dimitropoulou"></category></entry><entry><title>Tips for a Healthy Prostate</title><link href="http://www.fluinthenews.com/article/Tips%20for%20a%20Healthy%20Prostate" rel="alternate"></link><updated>2010-02-21T21:15:12Z</updated><author><name>Men's Fitness</name></author><id>tag:www.fluinthenews.com,2010-02-21:/article/Tips%20for%20a%20Healthy%20Prostate</id><summary type="html">&amp;lt;div&amp;gt;&amp;lt;p&amp;gt;According to the &lt;a title="American Cancer Society" href="/topic/American+Cancer+Society" &gt;American Cancer Society&lt;/a&gt;, more than 190,000 new cases of prostate cancer are diagnosed in the &lt;a title="United States" href="/topic/United+States" &gt;U.S.&lt;/a&gt; each year. Fortunately, there is a lot you can do to keep your prostate healthy as you age—and stay ahead of the game. Here's what &lt;a title="Christopher Saigal" href="/topic/Christopher+Saigal" &gt;Christopher Saigal&lt;/a&gt;, MD, an ass...</summary><category term="Food and Cooking"></category><category term="Foods"></category><category term="Fruits and Vegetables"></category><category term="Nuts and Edible Seeds"></category><category term="Diet and Nutrition"></category><category term="Healthy Eating"></category><category term="Cancer"></category><category term="Prostate Cancer"></category><category term="Sexual and Reproductive Health"></category><category term="Men's Health"></category><category term="Men's Fitness Magazine"></category><category term="Christopher Saigal"></category><category term="Jonsson Cancer Center"></category></entry><entry><title>J&amp;J drug helps in last-ditch prostate cancer fight</title><link href="http://www.fluinthenews.com/article/J%26J%20drug%20helps%20in%20last-ditch%20prostate%20cancer%20fight" rel="alternate"></link><updated>2010-02-22T09:12:16Z</updated><author><name>Reuters US Online Report Health News</name></author><id>tag:www.fluinthenews.com,2010-02-22:/article/J%26J%20drug%20helps%20in%20last-ditch%20prostate%20cancer%20fight</id><summary type="html">&amp;amp;lt;div&amp;amp;gt;&amp;amp;lt;p&amp;amp;gt;LONDON (&lt;a title="Reuters Group plc" href="/topic/Reuters+Group+plc" &gt;Reuters&lt;/a&gt;) - Johnson &amp;amp;amp;amp; Johnson's experimental drug abiraterone can help men with advanced prostate cancer who have run out of standard treatments options, according to results of a mid-stage clinical trial.&amp;amp;lt;/p&amp;amp;gt;&amp;amp;lt;p&amp;amp;gt;The drug, which J&amp;amp;amp;amp;J took on after buying &lt;a title="Cougar Biotechnology Inc." href="/topic/Cougar+Biotechnology+Inc." &gt;Cougar B...</summary><category term="Cancer"></category><category term="Prostate Cancer"></category><category term="Clinical Trials"></category><category term="Medical Treatments and Procedures"></category><category term="Medical Drug Therapy"></category><category term="Sexual and Reproductive Health"></category><category term="Technology"></category><category term="Biotechnology"></category><category term="Men's Health"></category><category term="Reuters Group plc"></category><category term="Royal Marsden Hospital"></category><category term="Johann de Bono"></category><category term="Cougar Biotechnology Inc."></category><category term="Taxotere"></category><category term="Ben Hirschler"></category></entry><entry><title>louis gossett jr</title><link href="http://www.fluinthenews.com/photo/2105315" rel="alternate"></link><updated>2010-02-09T18:16:50Z</updated><author><name>WENN</name></author><id>tag:www.fluinthenews.com,2010-02-09:/photo/2105315</id><summary type="html">*file photo*
* GOSSETT JR. BATTLING PROSTATE CANCER
Veteran actor &lt;a title="Louis Gossett Jr." href="/topic/Louis+Gossett+Jr." &gt;LOUIS GOSSETT JR.&lt;/a&gt; has been diagnosed with prostate cancer.
  The An Officer and a Gentleman star has started an intensive treatment programme to battle the disease.
  Gossett reveals the cancer is in its early stages and he's determined to remain optimistic so he can get back to work as soon as possible.
  He says, "I count this diagnosis among the many challenges I...</summary><category term="Cancer"></category><category term="Prostate Cancer"></category><category term="Sexual and Reproductive Health"></category><category term="Social Issues"></category><category term="African-American Issues"></category><category term="Men's Health"></category><category term="Western Europe"></category><category term="Louis Gossett Jr."></category><category term="London (England)"></category></entry><entry><title>Amgen sees positive data in bone drug study</title><link href="http://www.fluinthenews.com/article/Amgen%20sees%20positive%20data%20in%20bone%20drug%20study" rel="alternate"></link><updated>2010-02-22T10:35:48Z</updated><author><name>AP News</name></author><id>tag:www.fluinthenews.com,2010-02-22:/article/Amgen%20sees%20positive%20data%20in%20bone%20drug%20study</id><summary type="html">&amp;amp;lt;div id="subtitle"&amp;amp;gt;&lt;a title="Amgen Inc." href="/topic/Amgen+Inc." &gt;Amgen&lt;/a&gt; says potential bone drug tops rival in late-stage study on prostate cancer patients&amp;amp;lt;/div&amp;amp;gt;&amp;amp;lt;div&amp;amp;gt;&amp;amp;lt;p&amp;amp;gt;Amgen Inc. said its osteoporosis drug candidate denosumab beat a rival drug in reducing and delaying the rate of fractures in men with prostate cancer during a study.&amp;amp;lt;/p&amp;amp;gt;&amp;amp;lt;p&amp;amp;gt;The drug, also called Prolia, is viewed by &lt;a title="Wall Street" hre...</summary><category term="Financial Markets"></category><category term="Cancer"></category><category term="Prostate Cancer"></category><category term="Geriatric Medicine"></category><category term="Osteoporosis"></category><category term="Orthopedics"></category><category term="Sexual and Reproductive Health"></category><category term="Biotechnology Sector"></category><category term="Wall Street"></category><category term="Men's Health"></category></entry></feed>